ArticlePlants (Basel, Switzerland)2022
Effective Resistance to Four Fungal Foliar Diseases in Samples of Wild
Article in Plants (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 6 citations in OpenAlex.
- Unlocking the genetic potential ofFrontiers in plant science · 2026Review
- Enhancing aphid resistance in horticultural crops: a breeding prospective.Horticulture research · 2024Article
- Genetic Control of Effective Seedling Leaf Rust Resistance inPlants (Basel, Switzerland) · 2024Article
- Genetic Diversity for Effective Resistance in Wheat Landraces from Ethiopia and Eritrea to Fungal Diseases and Toxic Aluminum Ions.Plants (Basel, Switzerland) · 2024Article
- The Impact of Vavilov's Concept of the Centres of Crop Origin and Diversity on Research, Conservation, and Utilisation of Plant Genetic Resources Today: A Review on the Occasion of Vavilov's 135th Anniversary.Plants (Basel, Switzerland) · 2023Article
- Effective Resistance to Four Fungal Foliar Diseases in Samples of WildPlants (Basel, Switzerland) · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
Abstract
To identify new sources of effective resistance to four foliar diseases of wheat, 173 accessions of four wheat species, Triticum boeoticum, T. urartu, T. araraticum, and T. dicoccoides, from the VIR collection were tested at the juvenile and adult growth stages for resistance to leaf rust (Pt = Puccinia triticina), powdery mildew (Bgt = Blumeria graminis tritici), Septoria nodorum blotch (SNB), and dark-brown leaf spot blotch (HLB = Helminthospjrium leaf blotch). The accessions included new additions to the collection, some old samples that had never been tested before, as well as earlier tested samples noted for high levels of juvenile resistance to some fungal diseases. Natural populations of Puccinia triticina and Blumeria graminis f. sp. tritici, mixture of Parastagonospora nodorum and Bipolaris sorokiniana isolates were used to inoculate and to evaluate resistance to Pt, Bgt, SNB, and HLB, respectively. Two samples of T. boeoticum, three of T. urartu, and one of T. araraticum were resistant to leaf rust at both tested stages. Further tests (phytopathological and molecular analyses) excluded Lr9, Lr19, Lr24, Lr41, or Lr47 as single genes controlling resistance; hence, these accessions likely carry new effective leaf rust resistance genes. High level of Bgt resistance was identified in three entries of T. boeoticum, one of T. araraticum, and eleven of T. dicoccoides. All tested accessions were susceptible to HLB and SNB at both tested stages. Accessions identified as resistant are valuable plant material for introgressive hybridization in bread and durum wheat breeding. The results are discussed in the context of N.I. Vavilov’s concept of crop origin and diversity, and the laws of plant natural immunity to infectious diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.